Biocryst Pharmaceuticals buy StockNews.com
Start price
28.06.25
/
50%
€7.92
Target price
28.06.26
-
Performance (%)
-19.66%
Price
22:26
€6.46
Summary
This prediction is currently active. The price of Biocryst Pharmaceuticals has decreased since the start of the prediction. Compared to the start price this results in a performance of -19.66%. This prediction currently runs until 28.06.26. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biocryst Pharmaceuticals | -1.073% | -1.073% |
| iShares Core DAX® | 0.734% | 1.458% |
| iShares Nasdaq 100 | -2.686% | -0.146% |
| iShares Nikkei 225® | -2.261% | -2.729% |
| iShares S&P 500 | -1.346% | 0.467% |
Comments by StockNews_com for this prediction
In the thread Biocryst Pharmaceuticals diskutieren
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) was downgraded by analysts at Wall Street Zen from a "strong-buy" rating to a "buy" rating.
Ratings data for BCRX provided by MarketBeat